We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




RNAi Tools for Study of SARS Virus

By Biotechdaily staff writers
Posted on 12 Jun 2003
A library of short interfering RNA (siRNA) duplexes targeted against multiple regions of the coronavirus, believed to cause severe acute respiratory syndrome (SARS), is designed to help researchers study the lifecycle and pathogenicity of the virus and facilitate the development of therapeutics and vaccines. More...
Called SARS siArray Gene Set, the library is the product of Dharmacon, Inc. (Lafayette, CO, USA; www.dharmacon.com). The developers used the Toronto (Canada) SARS sequence, identifying 25 regions within the viral genome that carry the genetic information for key viral proteins that will be individually targeted with siRNA duplexes, including the 14 predicted open reading frames (ORFs).

"The SARS siArray Gene Set guarantees potent gene silencing and is priced to maximize its availability to a broad range of scientists seeking to unravel the molecular genetics of SARS pathogenesis,” said William S. Marshall, Ph.D., executive vice president of research and production at Dharmacon.

In a related development, Qiagen (Hilden, Germany) is also offering a SARS-Coronavirus siRNA Set, which allows gene silencing studies of coronavirus replication and cytopathology in mammalian cell culture. The 40 siRNA duplexes in the set were designed to target each of the 10 identified open reading frames (ORFs) of the SARS coronavirus. Regions of the ORFs were chosen that avoided known areas of sequence divergence in the genome sequences reported in GenBank. A comprehensive homology analysis was performed to ensure that there was no cross homology to known human genes, maximizing the gene-silencing potential.





Related Links:
Dharmacon
Qiagen

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.